Indication
In Vitro Fertilization
16 clinical trials
30 products
Product
OrgalutranClinical trial
Post-Marketing Surveillance Orgalutran (Ganirelix)®Status: Completed, Estimated PCD: 2007-12-01
Clinical trial
Effect of GnRH Agonist (Long Protocol) vs GnRH Antagonist (Flexible Protocol) on Oocyte Morphology During IVF/ICSIStatus: Completed, Estimated PCD: 2022-03-15
Product
TriptorelinClinical trial
Antioxidants-enriched Single-step vs Global Total Single-step Embryo Culture Media: Effect on Blastocyst Euploidy Rates.Status: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Transabdominal Fetal Reduction in Higher Order Multiple Pregnancies - a Pioneer Study in NepalStatus: Completed, Estimated PCD: 2023-04-30
Product
Fetal ReductionClinical trial
Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized TrialStatus: Recruiting, Estimated PCD: 2026-12-31
Product
MetforminProduct
Placebo pretreatmentClinical trial
Luteal Phase Support With GnRH Agonist Alone After GnRH Agonist Triggering and Fresh Embryo Transfer Compared to the Reference Protocol (hCG Triggering and Progesterone Luteal Support): a Randomised Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2027-09-01
Product
Triptorelin + NafarelinClinical trial
Effect of GnRH Agonist (Long Protocol) vs GnRH Antagonist (Flexible Protocol) on IVF/ICSI Outcomes.Status: Completed, Estimated PCD: 2022-01-01
Product
CetrorelixProduct
Human Chorionic GonadotropinClinical trial
Effect of GnRH Agonist (Long Protocol) vs GnRH Antagonist (Flexible Protocol) on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSIStatus: Completed, Estimated PCD: 2022-02-15
Product
Recombinant FSHProduct
Recombinant-FSHClinical trial
Effect of GnRH Agonist (Long Protocol) vs GnRH Antagonist (Flexible Protocol) on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.Status: Completed, Estimated PCD: 2021-08-15
Clinical trial
Frozen-thawed Embryo Transfer in a Natural Versus Artificial Cycle: a Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2024-04-01
Product
Natural cycleProduct
Estradiol ValerateProduct
Micronized progesteroneClinical trial
A Phase III, Uncontrolled Trial to Assess the Non-immunogenicity and Safety of Org 36286 in Patients Undergoing Repeated Controlled Ovarian Stimulation Cycles Using a Multiple Dose GnRH Antagonist ProtocolStatus: Completed, Estimated PCD: 2009-02-17
Product
Corifollitropin alfaProduct
FSHProduct
GnRH antagonistProduct
(rec)hCGProduct
ProgesteroneClinical trial
A Phase III, Randomized, Double-Blind, Active-Controlled, Non-Inferiority Clinical Trial to Investigate the Efficacy and Safety of a Single Injection of Org 36286 (Corifollitropin Alfa) to Induce Multifollicular Development for Controlled Ovarian Stimulation Using Daily Recombinant FSH as ReferenceStatus: Completed, Estimated PCD: 2007-11-19
Product
RecFSHProduct
RecFSH / Follitropin betaProduct
GanirelixProduct
hCGClinical trial
Vaginal Progesterone as Luteal Support for Improvement of Live Birth in Frozen/Thawed In-vitro Fertilization Natural Cycles; a Multicenter, Open, Randomized TrialStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
A Randomized Blinded Placebo Controlled Trial Assessing Ketorolac (Toradol) at Oocyte RetrievalStatus: Recruiting, Estimated PCD: 2023-12-01
Product
KetorolacClinical trial
Study of Analgesic Effect of Virtual Reality During Oocyte Retrieval in In Vitro Fecondation Protocols: Controlled Randomized TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Local anesthesiaClinical trial
What Should Be The Optimal Ovulation Triggering Size in Poseidon Group 4 Patients Undergoing Ovarian Stimulation?Status: Not yet recruiting, Estimated PCD: 2024-10-01
Product
recombinant hCG